Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00401-012-1044-y.

Title:
Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia | Acta Neuropathologica
Description:
Alzheimer’s disease (AD) can be classified based on the relative density of neurofibrillary tangles (NFTs) in the hippocampus and association cortices into three subtypes: typical AD, hippocampal-sparing AD (HpSp AD), and limbic-predominant AD (LP AD). AD subtypes not only have pathologic, but also demographic, clinical, and genetic differences. Neurofibrillary tangle-predominant dementia (NFTD), a disorder with NFTs relatively restricted to limbic structures, shares this feature with LP AD raising the possibility that NFTD is a variant of AD. The objective criteria for pathologic diagnosis of NFTD are not available. A goal of this study was to design a mathematical algorithm that could diagnose NFTD from NFT and senile plaque (SP) counts in hippocampus and association cortices, analogous to that used to subtype AD. Moreover, we aimed to compare pathologic, demographic, clinical, and genetic features of NFTD (n = 18) with LP AD (n = 19), as well as the other AD subtypes, typical AD (n = 52) and HpSp AD (n = 17). Using digital microscopy, we confirmed that burden of phospho-tau (CP13) and of an NFT conformational epitope (Ab39) correlated with NFT densities and showed expected patterns across AD subtypes. HpSp AD had the highest and LP AD had the lowest burden of cortical CP13 and Ab39 immunoreactivity. On the other hand, cortical β-amyloid burden did not significantly differ between AD subtypes. Semi-quantitative assessment of SPs in the basal ganglia did show HpSp AD to have significantly more frequent presence of SPs compared to typical AD, which was more frequent than LP AD. Compared to LP AD, NFTD had an older age at disease onset and shorter disease duration, as well as lower Braak NFT stage. NFTs and SPs on thioflavin-S fluorescent microscopy, as well as CP13, Ab39, and Aβ immunoreactivities were very low in the frontal cortex of NFTD, differentiating NFTD from AD subtypes, including LP AD. MAPT H1H1 genotype frequency was high (~70 %) in NFTD and LP AD, and similar to typical AD, while APOE ε4 carrier state was low in NFTD. While it shares clinical similarities with regard to female sex predominance, onset in advanced age, and a slow cognitive decline, NFTD has significant pathologic differences from LP AD, suggesting that it may not merely be a variant of AD.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Science
  • Health & Fitness

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,536 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We can't tell how the site generates income.

Not all websites focus on profit; some are designed to educate, connect people, or share useful tools. People create websites for numerous reasons. And this could be one such example. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {šŸ”}

article, google, scholar, disease, pubmed, alzheimers, cas, dementia, neurofibrillary, neuropathol, acta, alzheimer, subtypes, nftd, senile, neurol, clinical, study, research, murray, tangles, dickson, pathology, mayo, tanglepredominant, state, tangle, brain, hippocampal, exp, usa, privacy, cookies, content, typical, pathologic, braak, distinct, sclerosis, apolipoprotein, amyloid, brains, supported, clinic, journal, publish, search, significantly, ross, graffradford,

Topics {āœ’ļø}

neuritic amyloid plaques basal ganglia neurofibrillary tangle-predominant dementia digital microscopy month download article/chapter cortical β-amyloid burden log-normal size distribution short-term clinical outcomes mapt h1 haplotype tangle-predominant dementia nacp/alpha-synuclein immunoreactivity tangle predominant form neuropathologically defined subtypes late-onset alzheimer disease neocortical neurofibrillary tangles diffuse neurofibrillary tangles neurofibrillary tangle type full article pdf privacy choices/manage cookies showed expected patterns limbic predominant alzheimer limbic-predominant ad early-onset alzheimer late-onset alzheimer senile plaques inhibits abeta deposition human subject research cortical amyloid neurofibrillary tangles mayo adrc grant fluorescent microscopy disease research program show hpsp ad distinct clinical characteristics european economic area female sex predominance progressive supranuclear palsy knopman ds sporadic 4-repeat tauopathy heat-stable microtubule monica castanedes-casey pathogenetic aspects distinct ļæ½mini-mental stateā€ conditions privacy policy frontotemporal lobar degeneration shorter disease duration argyrophilic grain disease mayo clinic study article log nft conformational epitope

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia
         description:Alzheimer’s disease (AD) can be classified based on the relative density of neurofibrillary tangles (NFTs) in the hippocampus and association cortices into three subtypes: typical AD, hippocampal-sparing AD (HpSp AD), and limbic-predominant AD (LP AD). AD subtypes not only have pathologic, but also demographic, clinical, and genetic differences. Neurofibrillary tangle-predominant dementia (NFTD), a disorder with NFTs relatively restricted to limbic structures, shares this feature with LP AD raising the possibility that NFTD is a variant of AD. The objective criteria for pathologic diagnosis of NFTD are not available. A goal of this study was to design a mathematical algorithm that could diagnose NFTD from NFT and senile plaque (SP) counts in hippocampus and association cortices, analogous to that used to subtype AD. Moreover, we aimed to compare pathologic, demographic, clinical, and genetic features of NFTD (nĀ =Ā 18) with LP AD (nĀ =Ā 19), as well as the other AD subtypes, typical AD (nĀ =Ā 52) and HpSp AD (nĀ =Ā 17). Using digital microscopy, we confirmed that burden of phospho-tau (CP13) and of an NFT conformational epitope (Ab39) correlated with NFT densities and showed expected patterns across AD subtypes. HpSp AD had the highest and LP AD had the lowest burden of cortical CP13 and Ab39 immunoreactivity. On the other hand, cortical β-amyloid burden did not significantly differ between AD subtypes. Semi-quantitative assessment of SPs in the basal ganglia did show HpSp AD to have significantly more frequent presence of SPs compared to typical AD, which was more frequent than LP AD. Compared to LP AD, NFTD had an older age at disease onset and shorter disease duration, as well as lower Braak NFT stage. NFTs and SPs on thioflavin-S fluorescent microscopy, as well as CP13, Ab39, and Aβ immunoreactivities were very low in the frontal cortex of NFTD, differentiating NFTD from AD subtypes, including LP AD. MAPT H1H1 genotype frequency was high (~70Ā %) in NFTD and LP AD, and similar to typical AD, while APOE ε4 carrier state was low in NFTD. While it shares clinical similarities with regard to female sex predominance, onset in advanced age, and a slow cognitive decline, NFTD has significant pathologic differences from LP AD, suggesting that it may not merely be a variant of AD.
         datePublished:2012-09-12T00:00:00Z
         dateModified:2012-09-12T00:00:00Z
         pageStart:681
         pageEnd:692
         sameAs:https://doi.org/10.1007/s00401-012-1044-y
         keywords:
            Alzheimer disease
            Neurofibrillary tangle-predominant dementia
            APOE
            Digital microscopy
            MAPT
            Neurofibrillary tangles
            Amyloid plaques
            Basal ganglia
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig4_HTML.gif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:124
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Nicholas J. Janocko
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kevin A. Brodersen
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alexandra I. Soto-Ortolaza
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Owen A. Ross
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Amanda M. Liesinger
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ranjan Duara
               affiliation:
                     name:Mount Sinai Medical Center
                     address:
                        name:Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Neill R. Graff-Radford
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neurology, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dennis W. Dickson
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Melissa E. Murray
               affiliation:
                     name:Mayo Clinic
                     address:
                        name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Neuropathologically defined subtypes of Alzheimer’s disease differ significantly from neurofibrillary tangle-predominant dementia
      description:Alzheimer’s disease (AD) can be classified based on the relative density of neurofibrillary tangles (NFTs) in the hippocampus and association cortices into three subtypes: typical AD, hippocampal-sparing AD (HpSp AD), and limbic-predominant AD (LP AD). AD subtypes not only have pathologic, but also demographic, clinical, and genetic differences. Neurofibrillary tangle-predominant dementia (NFTD), a disorder with NFTs relatively restricted to limbic structures, shares this feature with LP AD raising the possibility that NFTD is a variant of AD. The objective criteria for pathologic diagnosis of NFTD are not available. A goal of this study was to design a mathematical algorithm that could diagnose NFTD from NFT and senile plaque (SP) counts in hippocampus and association cortices, analogous to that used to subtype AD. Moreover, we aimed to compare pathologic, demographic, clinical, and genetic features of NFTD (nĀ =Ā 18) with LP AD (nĀ =Ā 19), as well as the other AD subtypes, typical AD (nĀ =Ā 52) and HpSp AD (nĀ =Ā 17). Using digital microscopy, we confirmed that burden of phospho-tau (CP13) and of an NFT conformational epitope (Ab39) correlated with NFT densities and showed expected patterns across AD subtypes. HpSp AD had the highest and LP AD had the lowest burden of cortical CP13 and Ab39 immunoreactivity. On the other hand, cortical β-amyloid burden did not significantly differ between AD subtypes. Semi-quantitative assessment of SPs in the basal ganglia did show HpSp AD to have significantly more frequent presence of SPs compared to typical AD, which was more frequent than LP AD. Compared to LP AD, NFTD had an older age at disease onset and shorter disease duration, as well as lower Braak NFT stage. NFTs and SPs on thioflavin-S fluorescent microscopy, as well as CP13, Ab39, and Aβ immunoreactivities were very low in the frontal cortex of NFTD, differentiating NFTD from AD subtypes, including LP AD. MAPT H1H1 genotype frequency was high (~70Ā %) in NFTD and LP AD, and similar to typical AD, while APOE ε4 carrier state was low in NFTD. While it shares clinical similarities with regard to female sex predominance, onset in advanced age, and a slow cognitive decline, NFTD has significant pathologic differences from LP AD, suggesting that it may not merely be a variant of AD.
      datePublished:2012-09-12T00:00:00Z
      dateModified:2012-09-12T00:00:00Z
      pageStart:681
      pageEnd:692
      sameAs:https://doi.org/10.1007/s00401-012-1044-y
      keywords:
         Alzheimer disease
         Neurofibrillary tangle-predominant dementia
         APOE
         Digital microscopy
         MAPT
         Neurofibrillary tangles
         Amyloid plaques
         Basal ganglia
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-012-1044-y/MediaObjects/401_2012_1044_Fig4_HTML.gif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:124
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Nicholas J. Janocko
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kevin A. Brodersen
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alexandra I. Soto-Ortolaza
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Owen A. Ross
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Amanda M. Liesinger
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ranjan Duara
            affiliation:
                  name:Mount Sinai Medical Center
                  address:
                     name:Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Neill R. Graff-Radford
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neurology, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dennis W. Dickson
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Melissa E. Murray
            affiliation:
                  name:Mayo Clinic
                  address:
                     name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:124
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mount Sinai Medical Center
      address:
         name:Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neurology, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
      name:Mayo Clinic
      address:
         name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Nicholas J. Janocko
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Kevin A. Brodersen
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Alexandra I. Soto-Ortolaza
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Owen A. Ross
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Amanda M. Liesinger
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Ranjan Duara
      affiliation:
            name:Mount Sinai Medical Center
            address:
               name:Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, USA
               type:PostalAddress
            type:Organization
      name:Neill R. Graff-Radford
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neurology, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Dennis W. Dickson
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      name:Melissa E. Murray
      affiliation:
            name:Mayo Clinic
            address:
               name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Wien Center for Alzheimer’s Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, USA
      name:Department of Neurology, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
      name:Department of Neuroscience, Mayo Clinic, Jacksonville, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(152)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

4.44s.